Subcutaneous IVIG for Chronic Inflammatory Demyelinating Polyneuropathy

    loading  Checking for direct PDF access through Ovid


Synopsis:Compared to intravenous immunoglobulin, subcutaneous administration of immunoglobulin appears to have equal efficacy with more patient convenience.

Source: Markvardsen LH, et al. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2013; Jan. 7, 2013. DOI: 10.1111/ene.12080; [Epub ahead of print].

Related Topics

    loading  Loading Related Articles